APP Acquisition of Fujisawa Generics Adds Manufacturing Capability
Executive Summary
American Pharmaceutical Partners will gain 560 employees and 94 product lines when it acquires Fujisawa USA's generics business (formerly Lyphomed) in a deal expected to close in May.
You may also be interested in...
APP Accounts For 1% Of Premier Drug Spend: Response To Times Article
American Pharmaceutical Partners accounts for 1% of drugs purchased by Premier, the company said
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011